Literature DB >> 31254573

Evaluation of hyperhomocysteinemia prevalence and its influence on the selected cognitive functions in patients with schizophrenia.

Beata Trześniowska-Drukała1, Sylwia Kalinowska2, Krzysztof Safranow3, Karolina Kłoda4, Błażej Misiak5, Jerzy Samochowiec2.   

Abstract

There is evidence that hyperhomocysteinemia may be associated with the development of schizophrenia and cognitive impairment. Therefore, the aim of this study was to analyze the relationship between cognitive functions and normal homocysteine concentrations vs. hyperhomocysteinemia in schizophrenia patients before and after supplementation with vitamins B6, B12 and folate. An 8-week prospective, non-randomized study enrolled 122 adult patients with schizophrenia (67F/55M, mean age 43.54 ± 11.94 years). Homocysteine concentrations were measured in all individuals and afterwards hyperhomocysteinemia patients (n = 42) were divided into two subgroups: treated with oral vitamins supplementation (B6 - 25 mg/d, B12 - 20 μg/d, folate - 2,5 mg/d) (n = 22) and without supplementation (n = 20). The assessment of schizophrenia symptoms severity in study group was performed using the Positive and Negative Syndrome Scale (PANSS). Cognitive functions were evaluated using the Stroop test and the Trail Making Test (TMT). We observed a higher prevalence of hyperhomocysteinemia in schizophrenia patients (34.4%) in comparison to the general population. Individuals with schizophrenia and coexisting hyperhomocysteinemia had worse performance on the Stroop and the TMT tests as well as higher PANSS scores. In these patients, supplementation with vitamins effectively decreased the homocysteine concentrations to the normal values, however there was no statistically significant improvement in the PANSS and cognitive test scores, except a significant decrease in the number of the Stroop test errors. We conclude that significant results obtained in this study show that there is a relationship between homocysteine blood concentration and schizophrenia severity. Moreover, homocysteine concentration lowering might be beneficial in schizophrenia patients with hyperhomocysteinemia in terms of cognitive functions improvement.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive function; Folate; Homocysteine; Schizophrenia; Vitamins B

Year:  2019        PMID: 31254573     DOI: 10.1016/j.pnpbp.2019.109679

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  6 in total

1.  Interactive effect of MTHFR C677T polymorphism and sex on symptoms and cognitive functions in Chinese patients with chronic schizophrenia.

Authors:  Jie Gao; Mei Hong Xiu; Dian Ying Liu; Chang Wei Wei; Xiangyang Zhang
Journal:  Aging (Albany NY)       Date:  2020-06-04       Impact factor: 5.682

2.  Association between plasma homocysteine levels and cognitive deficits in Han Chinese patients with schizophrenia across age groups.

Authors:  Sumiao Zhou; Yuanyuan Huang; Yangdong Feng; Hehua Li; Kai Wu; Mingzhe Yang; Fengchun Wu; Xingbing Huang
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

3.  Consensus on potential biomarkers developed for use in clinical tests for schizophrenia.

Authors:  Ping Lin; Junyu Sun; Xiaoyan Lou; Dan Li; Yun Shi; Zhenhua Li; Peijun Ma; Ping Li; Shuzi Chen; Weifeng Jin; Shuai Liu; Qing Chen; Qiong Gao; Lili Zhu; Jie Xu; Mengyuan Zhu; Mengxia Wang; Kangyi Liang; Ling Zhao; Huabin Xu; Ke Dong; Qingtian Li; Xunjia Cheng; Jinghong Chen; Xiaokui Guo
Journal:  Gen Psychiatr       Date:  2022-02-23

4.  The Effects of Plasma Homocysteine Level on the Risk of Three Major Psychiatric Disorders: A Mendelian Randomization Study.

Authors:  Jing Yu; Ranran Xue; Qiuling Wang; Hao Yu; Xia Liu
Journal:  Front Psychiatry       Date:  2022-03-21       Impact factor: 4.157

5.  Polymorphism of Transferrin Gene Impacts the Mediating Effects of Psychotic Symptoms on the Relationship between Oxidative Stress and Cognition in Patients with Chronic Schizophrenia.

Authors:  Pinhong Chen; Dongmei Wang; Meihong Xiu; Dachun Chen; Blake Lackey; Hanjing E Wu; Jin Zhou; Xiangyang Zhang
Journal:  Antioxidants (Basel)       Date:  2022-01-06

6.  Prevalence and clinical demography of hyperhomocysteinemia in Han Chinese patients with schizophrenia.

Authors:  Yating Yang; Juan Wang; Zulun Xiong; Xianhu Yao; Yulong Zhang; Xiaoshuai Ning; Yi Zhong; Zhiwei Liu; Yelei Zhang; Tongtong Zhao; Lei Xia; Kai Zhang; Huanzhong Liu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-06-08       Impact factor: 5.270

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.